• <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    来宝网Logo

    热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

    现在位置首页>技术资料首页>行业动态>公司动态>Amedisys完成收购Hackensack大学医学中心的家庭医疗事业

    Amedisys完成收购Hackensack大学医学中心的家庭医疗事业

    Amedisys2010年1月21日 20:29 点击:2178

    美国Amedisys
    AMEdisys (AMED)宣布,获得纽泽西州主管当局核准,已经完成收购Hackensack大学医学中心的家庭医疗事业,这件交易代表Amedisys首次跨入纽泽西州的家庭医疗市场,该事?#30340;?#33829;收约1900万美元,服务Bergen与Hudson郡。

    BATON ROUGE, Louisiana (January 4, 2010) - Amedisys, Inc. (NASDAQ: "AMED"), one of America's leading home health nursing companies, today announced that it has received the regulatory approvals from the state of New Jersey and that it has completed the acquisition of the home health operations of Hackensack University Medical Center. This acquisition represents Amedisys’ initial entry into the home health business in New Jersey, a certificate of need (CON) state. The agency has annualized revenue of approximately $19 million and serves Bergen and Hudson counties.

    “We welcome the employees from the Hackensack home health agency into the Amedisys family. We are very excited about this opportunity to provide services in New Jersey,” stated William F. Borne, Chief Executive Officer of Amedisys, Inc. “This marks our initial entrance into New Jersey, a state with a significant number of Medicare beneficiaries. We look forward to building on the excellent care and service the agency currently provides to the patients in this community by introducing Amedisys clinical programs, providing additional financial and operational resources, and expanding business development efforts.”

    Amedisys, Inc. is headquartered in Baton Rouge, Louisiana. Its common stock trades on the NASDAQ Global Select Market under the symbol “AMED”.

    This press release includes statements that may constitute “forward-looking” statements, usually containing the words “believe”, “estimate”, “project”, “expect”, “anticipate” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Many of the factors that could cause or contribute to such differences are described in the Company’s periodic reports and registrations statements filed with the Securities and Exchange Commission, and include, but are not limited to the following: general economic and business conditions, changes in or failure to comply with existing regulations or the inability to comply with new government regulations on a timely basis, changes in Medicare and other medical reimbursement levels, ability to complete acquisitions announced from time to time, and any financing related thereto, the ability to meet debt service requirements and to comply with covenants in debt agreements, adverse changes in federal and state laws relating to the health care industry, demographic changes, availability and terms of capital, ability to attract and retain qualified personnel, ongoing development and success of new start-ups, ability to successfully integrate newly acquired agencies, changes in estimates and judgments associated with critical accounting policies, business disruption due to natural disasters or acts of terrorism, and various other matters, many of which are beyond management’s control. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

    Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the “Investor Relations” subpage of our website, which is accessible by clicking on the tab labeled “Investors” on our website home page. We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission (“SEC”) disclosing the same information. In addition, we make available on the Investor Relations subpage of our website (under the link “SEC filings”) free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link “Corporate Governance”).

    (来源: Amedisys )


    全年征稿 / 资讯合作

    联系邮箱:[email protected]

    版权与免责声明

    • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://www.67994619.com,违反者本网将追究相关法律责任。
    • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
    • 如涉及作品内容、版权?#20219;?#39064;,请在作品发表之日起一周内与本网联系,否则视为?#29260;?#30456;关权利。


    云南11选5技巧
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    马会传真报图片2019 分分彩分多少种 3的走势带连线 福福建快三开奖结果直播 今日云南十一选五预测专家 百家乐赌经 中国福彩网积分兑换 广东时时彩赌博案 足彩胜负彩奖金 广东时时彩qq群查找 上海快3结果 北京快乐8漏洞 福彩3d陈华今晚独胆一 魔术扑克背面认牌 吉林快三50期开奖结果